fbpx

NeoDynamics – Presentation of Q3 quarterly results

NeoDynamics - Presentation of Q3 quarterly results 17 NovemberNov 2021 12:00 - 12:30Online Event

NeoDynamics – Presentation of Q3 quarterly results

Watch live when the CEO of NeoDynamics, Anna Eriksrud present the Q3 quarterly financial results. During the event, it will be possible to ask questions.

A few weeks ago, NeoDynamics announced that the company has started a subsidiary in Germany to grow in the German market with the innovative biopsy system NeoNavia. NeoDynamics has already initiated the launch of NeoNavia in Germany as well as in neighboring countries and has received the first initial orders.

NeoDynamics AB is a Swedish medical technology company. The company is engaged in offering precision cancer management for improved patient care. It has developed the NeoNavia biopsy system, which utilizes a patented micropulse technology to simplify and improve precision in biopsy sampling in breast cancer patients.

Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a Digital IR / Corporate Visibility subscription agreement.

Deltag her

Du vil blive videresendt til en ekstern tilmeldingsside. 

Information

NeoDynamics - Presentation of Q3 quarterly results 17 NovemberNov 2021 12:00 - 12:30
NeoDynamics - Presentation of Q3 quarterly results Online Event
NeoDynamics - Presentation of Q3 quarterly results 17 NovemberNov 2021 12:00 - 12:30Online Event

NeoDynamics – Presentation of Q3 quarterly results

Watch live when the CEO of NeoDynamics, Anna Eriksrud present the Q3 quarterly financial results. During the event, it will be possible to ask questions.

A few weeks ago, NeoDynamics announced that the company has started a subsidiary in Germany to grow in the German market with the innovative biopsy system NeoNavia. NeoDynamics has already initiated the launch of NeoNavia in Germany as well as in neighboring countries and has received the first initial orders.

NeoDynamics AB is a Swedish medical technology company. The company is engaged in offering precision cancer management for improved patient care. It has developed the NeoNavia biopsy system, which utilizes a patented micropulse technology to simplify and improve precision in biopsy sampling in breast cancer patients.

Disclaimer: HC Andersen Capital receives payment from NeoDynamics for a Digital IR / Corporate Visibility subscription agreement.

Information

NeoDynamics - Presentation of Q3 quarterly results 17 NovemberNov 2021 12:00 - 12:30
NeoDynamics - Presentation of Q3 quarterly results Online Event